Prema Prema

Dr. Prema Prema

Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Pharmacological Reviews
Verified
Journal Article
Open access
PDF file
UBUddalak Bharadwaj
Uddalak Bharadwaj
MKMoses M. Kasembeli
Moses M. Kasembeli
PPPrema Prema
Prema Prema
DTDavid Tweardy
David Tweardy
Before it was molecularly cloned in 1994, acute-phase response factor or signal transducer and activator of transcription (STAT)3 was the focus of intense research into understanding the mammalian response to injury, particularly the acute-phase response. Although known to be essential for liver production of acute-phase reactant proteins, many of which augment innate immune responses, molecular cloning of acute-phase response factor or STAT3 and the research this enabled helped establish the central function of Janus kinase (JAK) family members in cytokine signaling and identified a multitude of cytokines and peptide hormones, beyond interleukin-6 and its family members, that activate JAKs and STAT3, as well as numerous new programs that their activation drives. Many, like the acute-phase response, are adaptive, whereas several are maladaptive and lead to chronic inflammation and adverse consequences, such as cachexia, fibrosis, organ dysfunction, and cancer. Molecular cloning of STAT3 also enabled the identification of other noncanonical roles for STAT3 in normal physiology, including its contribution to the function of the electron transport chain and oxidative phosphorylation, its basal and stress-related adaptive functions in mitochondria, its function as a scaffold in inflammation-enhanced platelet activation, and its contributions to endothelial permeability and calcium efflux from endoplasmic reticulum. In this review, we will summarize the molecular and cellular biology of JAK/STAT3 signaling and its functions under basal and stress conditions, which are adaptive, and then review maladaptive JAK/STAT3 signaling in animals and humans that lead to disease, as well as recent attempts to modulate them to treat these diseases. In addition, we will discuss how consideration of the noncanonical and stress-related functions of STAT3 cannot be ignored in efforts to target the canonical functions of STAT3, if the goal is to develop drugs that are not only effective but safe. Significance Statement Key biological functions of Janus kinase (JAK)/signal transducer and activator of transcription (STAT)3 signaling can be delineated into two broad categories: those essential for normal cell and organ development and those activated in response to stress that are adaptive. Persistent or dysregulated JAK/STAT3 signaling, however, is maladaptive and contributes to many diseases, including diseases characterized by chronic inflammation and fibrosis, and cancer. A comprehensive understanding of JAK/STAT3 signaling in normal development, and in adaptive and maladaptive responses to stress, is essential for the continued development of safe and effective therapies that target this signaling pathway.

Verified
Journal Article
Open access
PDF file
MKMoses Kasembeli
Moses Kasembeli
UBUddalak Bharadwaj
Uddalak Bharadwaj
PPPrema Prema
Prema Prema
DTDavid Tweardy
David Tweardy
Signal transducer and activator of transcription (STAT) 3 plays a central role in the host response to injury. It is activated rapidly within cells by many cytokines, most notably those in the IL-6 family, leading to pro-proliferative and pro-survival programs that assist the host in regaining homeostasis. With persistent activation, however, chronic inflammation and fibrosis ensue, leading to a number of debilitating diseases. This review summarizes advances in our understanding of the role of STAT3 and its targeting in diseases marked by chronic inflammation and/or fibrosis with a focus on those with the largest unmet medical need.

1 October 2004 in The FASEB Journal
Verified
Journal Article
Closed access
Ashok KumarAshok Kumar
Ashok Kumar
RMRyan Murphy
Ryan Murphy
PPPrema Prema
Prema Prema
LWLei Wei
Lei Wei
ABAladin M. Boriek
Aladin M. Boriek

1 January 2008 in Infection and Immunity
Verified
Journal Article
Closed access
PDF file
BPBirte Pantenburg
Birte Pantenburg
SDSara M. Dann
Sara M. Dann
HWHeuy-Ching Wang
Heuy-Ching Wang
PPPrema Prema
Prema Prema
ACAlejandro Castellanos-Gonzalez
Alejandro Castellanos-Gonzalez
AWA. Clinton White
A. Clinton White
Cryptosporidium is an obligate intracellular protozoan parasite that is a major cause of diarrheal illness worldwide. Cryptosporidium primarily infects the distal small intestine. Immunocompetent hosts control and eliminate the infection, which typically causes acute, self-limited watery diarrhea

1 October 2005 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
SDSara M. Dann
Sara M. Dann
HWHeuy-Ching Wang
Heuy-Ching Wang
KGKimberly J. Gambarin
Kimberly J. Gambarin
JAJeffrey Actor
Jeffrey Actor
PPPrema Prema
Prema Prema
AWA. Clinton White
A. Clinton White
Intracellular protozoans of the genus Cryptosporidium are a major cause of diarrheal illness worldwide, but little is known about the mechanisms that

1 February 2000 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
AWA. Clinton White
A. Clinton White
PPPrema Prema
Prema Prema
POPablo C. Okhuysen
Pablo C. Okhuysen
DLDorothy E. Lewis
Dorothy E. Lewis
ISImram Shahab
Imram Shahab
CCCynthia L. Chappell
Cynthia L. Chappell
To investigate the role of interferon (IFN)-γ in human cryptosporidiosis, jejunal biopsies from experimentally infected volunteers and chronically in